Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Portella, C. Laezza, P. Laccetti, L. Petrocellis, V. Marzo, M. Bifulco (2003)
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasisThe FASEB Journal, 17
S. Kishimoto, Maiko Gokoh, Saori Oka, M. Muramatsu, T. Kajiwara, K. Waku, T. Sugiura (2003)
2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism*Journal of Biological Chemistry, 278
P. Massi, A. Vaccani, S. Ceruti, A. Colombo, M. Abbracchio, D. Parolaro (2004)
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell LinesJournal of Pharmacology and Experimental Therapeutics, 308
R. Pertwee, R. Ross (2002)
Cannabinoid receptors and their ligands.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
Z. Járai, J. Wagner, J. Wagner, K. Varga, K. Lake, D. Compton, B. Martin, A. Zimmer, T. Bonner, N. Buckley, É. Mezey, R. Razdan, A. Zimmer, G. Kunos (1999)
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.Proceedings of the National Academy of Sciences of the United States of America, 96 24
C. Sánchez, I. Galve-Roperh, C. Canova, P. Brachet, M. Guzmán (1998)
Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cellsFEBS Letters, 436
D. Parolaro, P. Massi, T. Rubino, E. Monti (2002)
Endocannabinoids in the immune system and cancer.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
L. Walter, A. Franklin, Anke Witting, C. Wade, Yiheng Xie, G. Kunos, K. Mackie, N. Stella (2003)
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell MigrationThe Journal of Neuroscience, 23
P. Sacerdote, P. Massi, A. Panerai, D. Parolaro (2000)
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptorsJournal of Neuroimmunology, 109
M. Roth, G. Baldwin, D. Tashkin (2002)
Effects of delta-9-tetrahydrocannabinol on human immune function and host defense.Chemistry and physics of lipids, 121 1-2
M. Jordà, S. Verbakel, P. Valk, Yolanda Vankan-Berkhoudt, M. Maccarrone, A. Finazzi-Agrò, B. Löwenberg, R. Delwel (2002)
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.Blood, 99 8
J. Joseph, B. Niggemann, K. Zaenker, F. Entschladen (2004)
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytesCancer Immunology, Immunotherapy, 53
A. Howlett, F. Barth, T. Bonner, G. Cabral, P. Casellas, W. Devane, C. Felder, M. Herkenham, K. Mackie, B. Martin, R. Mechoulam, R. Pertwee (2002)
International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 54
M. Guzmán (2003)
Cannabinoids: potential anticancer agentsNature Reviews Cancer, 3
T. Bisogno, L. Hanuš, L. Petrocellis, S. Tchilibon, D. Ponde, I. Brandi, A. Moriello, John Davis, R. Mechoulam, V. Marzo (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBritish Journal of Pharmacology, 134
C. Sánchez, I. Galve-Roperh, C. Canova, P. Brachet, M. Guzmán (1998)
Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.FEBS letters, 436 1
J. Pharmacol. Exp. Ther
C. Song, A. Howlett (1995)
Rat brain cannabinoid receptors are N-linked glycosylated proteins.Life sciences, 56 23-24
S. Carlisle, Francine Marciano-Cabral, A. Staab, C. Ludwick, Guy Cabral (2002)
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation.International immunopharmacology, 2 1
We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by conditioned medium. CBD caused concentration‐dependent inhibition of the migration of U87 glioma cells, quantified in a Boyden chamber. Since these cells express both cannabinoid CB1 and CB2 receptors in the membrane, we also evaluated their engagement in the antimigratory effect of CBD. The inhibition of cell was not antagonized either by the selective cannabinoid receptor antagonists SR141716 (CB1) and SR144528 (CB2) or by pretreatment with pertussis toxin, indicating no involvement of classical cannabinoid receptors and/or receptors coupled to Gi/o proteins. These results reinforce the evidence of antitumoral properties of CBD, demonstrating its ability to limit tumor invasion, although the mechanism of its pharmacological effects remains to be clarified. British Journal of Pharmacology (2005) 144, 1032–1036. doi:10.1038/sj.bjp.0706134
British Journal of Pharmacology – Wiley
Published: Apr 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.